江浙沪地区汉人HLA－DQA1基因对重症肌无力的遗传易感性研究

采用一种新的多聚酶链反应－限制性片段长度多态性（ＰＣＲ－ＲＦＬＰ）基因分型法，研究了江浙沪地区中国汉人重症肌无力（ｍｙａｓｔｈｅｎｉａｇｒａｖｉｓ，ＭＧ）４５例和对照组９８例的ＨＬＡ－ＤＱＡ１等位基因。发现ＭＧ的胸腺瘤型和非胸腺瘤型ＤＱＡ１基因遗传背景有所不同，ＨＬＡ－ＤＱＡ１＊０３０１基因参与非胸腺瘤型ＭＧ（尤其是男性组）的遗传易感作用（ＲＲ＝３．６３，Ｐ＜０．０５），家系分析支持群体研究结果。推测了中国汉人ＭＧ可能的ＨＬＡ易感单体型：ＤＱＡ１＊０３０１ＤＱＢ１＊０３０３－ＤＲＢ１＊０９０１和ＤＱＡ１＊０３０１－ＤＱＢ１＊０３０３－ＤＲＢ１＊０４０６．结果从基因分型的角度统一了关于华人ＭＧ与ＨＬＡ相关抗原提法不一致的报道，并揭示了ＭＧ的其它ＨＬＡⅡ系统易感基因ＤＱＢ１＊０３０１、ＤＲＢ１＊０９０１及ＤＲＢ１＊０４０６或ＤＢＲ＊０４０５存在的极大可能性。为进一步分析ＭＧ的遗传易感机理提供了重要依据。     

HLA—DQA1,DQB1,DRB1＊02,07,09等位基因及单倍型在华东地区汉？…

应用ＰＣＲ－ＳＳＯ方法，对华东地区汉族人群进行了ＨＬＡ－ＤＱＡ１，ＤＱＢ１和ＤＲＢ１＊０２，０７，０９基因分型，ＤＱＡ１中以ＤＱＡ１＊０３０１基因频率最高，其次为＊０５０１和０１０２，＊０４０１最低，ＤＱＢ１中以ＤＱＢ１＊０３０３频率最高，其次为＊０．３０１，＊０６０１和＊０２０１，＊０５０１，＊０６０４和＊０６０５最低；ＤＲ９基因频率较高，ＤＲ２中ＤＲＢ１＊１５０１占７３５，基因频率为０．０８５     

HLA-DQA1、DQB1、DRB1 02,07,09等位基因及单倍型在华东地区汉族人群的分布

应用ＰＣＲ－ＳＳＯ方法，对华东地区汉族人群进行了ＨＬＡ－ＤＱＡ１、－ＤＱＢ１和ＤＲＢ１＊０２，０７，０９基因分型。ＤＱＡ１中以ＤＱＡ１＊０３０１基因频率最高（０．３８４４），其次为＊０５０１（０．１４０６）和０１０２（０．１２１９），＊０４０１最低（０．０２８１）；ＤＱＢ１中以ＤＱＢ１＊０３０３基因频率最高（０．２３４２），其次为＊０３０１（０．１８９９）、＊０６０１（０．１２０３）和＊０２０１（０．１１０８），＊０５０１、＊０６０４和＊０６０５最低（均为０．０１２７）；ＤＲ９基因频率较高（０．２３１０），ＤＲ２中ＤＲＢ１＊１５０１占７３％，基因频率为０．０８５４，未见＊１６０１。ＤＱＡ１、ＤＱＢ１及ＤＲＢ１等位基因之间存在显著的连锁不平衡。ＤＲＢ１＊０９０１－ＤＱＡ１＊０３０１－ＤＱＢ１＊０３０３、ＤＱＡ１＊０１０３－ＤＱＢ１＊０６０１等为常见单倍型。本资料与我国其他汉族人群资料有可比性，也存在一定差异。     

中国湖北汉族重症肌无力与HLA-Ⅱ类等位基因的关联

目的和方法：探讨中国湖北汉族重症肌无力（ＭＧ）患者与ＨＬＡ－Ⅱ类等位基因的关联。利用ＰＣＲ／ＳＳＰ和ＰＣＲ－ＲＦＬＰ技术对湖北地区９１例ＭＧ患者进行ＨＬＡ－Ⅱ类（ＨＬＡ－ＤＲＢ１、ＤＱＢ１和ＤＰＢ１）基因型别分析,民１６８例正常个体比较。结果：患者组（１）：ＨＬＡ－ＤＲＢ１＊０９０１、ＤＱＢ１＊０３０３和ＤＰＢ１＊０５０１等位基因频率明显高于对照组,ＲＲ值分别为４．１２、３．０４和３．０１,Ｐ〈０     

HLA—DR,DQ基因多态性与系统性红斑狼疮相关性的研究

应用聚合酶链反应结合顺序特异的寡核苷酸探针杂交（ＰＣＲ／ＳＳＯＰＨ）方法对江苏籍汉族ＳＬＥ患者和健康对照组ＨＬＡ－ＤＲＢ１、ＤＱＡ１：ＤＱＢ１基因作寡核苷酸分型。结果发现患者组中ＤＲＢ１＊１５０１、ＤＱＡ１＊０１０２等位基因频率及ＨＬＡ－ＤＲＢ１＊１５０１、－ＤＱＡ１＊０１０２、－ＤＱＢ１＊０６０２单倍型频率均明显高于正常对照组；相反，ＤＲＢ１＊０４（ＤＲ４）、ＤＱＡ１＊０６０１频率则明显低于正常对照组。所有ＤＱＢ１等位基因频率在两组间无显著差异，而ＤＱＡ１＊０１０２仅存在于ＤＲ２阳性的个体之中，推测汉族ＳＬＥ的易感基因可能靠近ＤＲ位点，且与单倍型ＨＬＡ－ＤＲＢ１＊１５０１、－ＤＱＡ１＊０１０２、－ＤＱＢ１＊０６０２紧密连锁，该单倍型可作为汉族ＳＬＥ易感的遗传标记。相反ＤＲ４，ＤＱＡ１＊０６０１则对ＳＬＥ发病可能有一定的保护性。     

抗磷脂抗体阳性SLE患者HLA DRB1、DQA1、DQB1基因单倍型研究

本文采用ＰＣＲ ＲＦＬＰ技术对抗磷脂抗体阳性（ＡＰＡ＋）ＳＬＥ患者ＨＬＡ ＤＲＢ１、ＤＱＡ１ 和ＤＱＢ１ 基因进行分型研究, 同时以上海地区汉族随机人群作对照, 发现这类病人的ＤＲＢ１＊ ０８０３ ＤＱＡ１＊ ０１０３ ＤＱＢ１ ＊０６０１ 单倍型频率显著增高（ Ｐ＜ ０－０１） 相对危险率为４－４５, 说明该疾病与此单倍型存在着很强的关联。     

家族性热性惊厥与HLA—D区基因关联性的研究

为探讨家族性热性惊厥与ＨＬＡ－Ｄ区基因的关系，应用限制性片段长度多态性方法，对５０个简单型热性惊厥（ｆｅｂｒｉｌｅｃｏｎｖｕｌｓｉｏｎｓ，ＦＣ）患儿及家系成员进行了人类白细胞抗原（ＨＬＡ）ＤＲ、ＤＱ区等位基因分型，并以１０１例健康人做对照。结果显示，ＨＬＡ－ＤＲ、ＤＱ区各等位基因在ＦＣ患者及有ＦＣ史亲属组中的频率较健康对照组无明显增高；而ＨＬＡ－ＤＲβ９（ＨＬＡＤＲＢ１＊０９０１）及ＤＱβ３ａ（ＤＱＢ１＊０３０２－０３０３，０４０１－０４０２）等位基因的表型频率较健康对照组明显降低。家系中无ＦＣ史亲属组中ＨＬＡ各等位基因的分布与健康对照组无差异。结果提示，ＨＬＡ－ＤＲ、ＤＱ基因区域内未发现与ＦＣ易感性有关的等位基因型。作为健康人群中频率最高的等位基因型。ＨＬＡ－ＤＲβ９和ＤＱβ３ａ等位基因可能具有某种生物学优势，在抵抗ＦＣ发病中起一定作用。     

用PCR-SSP方法研究广西壮族HLA-DQA1和B1基因多态性

目的　检测广西壮族ＨＬＡＤＱＡ１ ,Ｂ１ 基因的多态性。方法　应用ＰＣＲＳＳＰ 方法对１４０ 名健康、无血缘关系广西壮族人的ＨＬＡＤＱＡ１ 和ＤＱＢ１ 进行基因分型。结果　共检出７ 个ＤＱＡ１ 等位基因和１６ 个ＤＱＢ１ 等位基因。在检出的ＤＱＡ１ 等位基因中,０３０１ 的基因频率最高（３５ ％ ） ,０４０１ 的基因频率最低（１ ．１ ％ ） 。在ＤＱＢ１ 等位基因中,０６０１（２２ ．１ ％ ） ,０３０１（２０ ．７ ％ ） ,０５０１（１３ ．９ ％ ） 最为常见。未检出的等位基因包括ＨＬＡＤＱＡ１ ＊ ０２０１ ,０３０２ ,０６０１ ,ＤＱＢ１ ＊ ０６０３ ,０６０５ 和０６０８ 。结论　广西壮族ＨＬＡＤＱＡ１ ,Ｂ１ 基因的多态性不仅有中华民族的特点,而且也有其独特性。     

上海地区多发性硬化症与HLAⅡ类基因和抗原处理相？…

探讨上海人群中ＨＬＡⅡ类基因和抗原处理相关基因与多发性硬化症的相关性。方法,用ＰＣＲ－ＲＦＬＰ和ＰＣＲ－ＳＳＯ技术对２１名上海地区无血缘关系的ＭＳ患者和８９名正常人作ＨＬＡⅡ类（ＨＬＡ－ＤＲＢ１,－ＤＱＡ１和－ＤＱＢ１）和抗原处理相关基因（ＴＡＰ１,ＴＡＰ２和ＬＭＰ２）分型。结果患者组ＤＲＢ１＊０４０５、Ｔ 克＊０５０２（Ｐ＝０．００２５）等位基因ＤＲＢ１＊０４０５－ＤＱＡ１＊０３０１－ＤＱＢ１＊     

用PCR—RFLP方法研究新疆地区汉族HLA—DQA1和—DQB1基因多态性

应用ＰＣＲ－ＲＦＬＰ技术，对新疆地区汉族健康群体进行了ＨＬＡ－ＤＱＡ１（４９人）和ＤＱＢ１（４７人）基因分型。在ＤＱＡ１１８个等位基因中，ＤＱＡ１＊０３０１的基因频率最高（３２．５６％），＊０４０１最低（１．０２％）。在ＤＱＢ１１６个等位基因中，ＤＱＢ１＊０２０１（２０．２１％），＊０３０１（１５．９６％）、＊０３０３（１４．８９％）为最常见；没有观察到＊０５０３２、＊０５０４和＊０６０５。与河北     

北方汉族HLA-DRB1、DQB1基因多态性的研究

目的从基因水平了解北方汉族ＨＬＡ－ＤＲＢ１、ＤＱＢ１多态性分布,获得更完整、更准确的遗传学数据。方法应用ＰＣＲ－ＳＳＰ方法对１０７名北方汉族健康人进行了ＨＬＡ－ＤＲＢ１、ＤＱＢ１等位基因分型。结果鉴定了１４个ＤＲＢ１等位基因,９个ＤＱＢ１等位基因,包括了ＤＲ、ＤＱ位点的全部血清学特异性。结论提供了一套比较完整准确的ＤＲＢ１、ＤＱＢ１等位基因的基因频率和连锁不平衡参数。对群体遗传和疾病关联的研究具有重要的意义。     

人白细胞抗原DQB1基因与1型糖尿病相关性研究

目的　研究四川地区汉族人群人类白细胞抗原 (humanleucocyteantigen ,HLA)DQB1基因与 1型糖尿病 (type 1diabetesmellitus ,T1DM )发病年龄及糖尿病自身抗体的相关性。 方法　应用聚合酶链反应 序列特异性引物方法对 46例T1DM患者和 5 2名正常人进行HLA DQB1基因分型 ,并对T1DM患者以酶联免疫吸附法定性检测谷氨酸脱羧酶抗体 (glutamicaciddecarboxylaseantibody ,GADA)及抗胰岛细胞抗体 (isletcellantibody ,ICA)。结果　DQB1 0 2 0 1基因阳性率T1DM组高于对照组 (OR =18,P <0 .0 0 5 ) ;而DQB1 0 60 1、 0 60 2基因阳性率对照组高于T1DM组 (OR分别为 0 .0 7、0 3 1,P <0 .0 5 )。DQB1 0 60 2基因阳性率在发病年龄≥ 2 0岁T1DM组高于 <2 0岁组 (P <0 .0 5 )。携带DQB1 0 2 0 1基因的患者中 ,GADA阳性率明显高于此基因阴性的患者 (P <0 .0 2 5 )。结论　四川地区汉族人群中DQB1 0 2 0 1可能是 1型糖尿病的易感基因 ,而DQB1 0 60 2、 0 60 1是保护性基因 ,且DQB1 0 60 2基因的存在有可能推迟 1型糖尿病的发病 ;DQB1 0 2 0 1的阳性率与GADA阳性率正相关。     

Analysis of high‐resolution HLA‐A, ‐B, ‐Cw, ‐DRB1, and ‐DQB1 alleles and haplotypes in 718 Chinese marrow donors based on donor–recipient confirmatory typings

High‐resolution human leucocyte antigen (HLA)‐A, ‐B, ‐Cw, ‐DRB1, and ‐DQB1 alleles and haplotype frequencies were analysed from 718 Chinese healthy donors selected from the Chinese Marrow Donor Program registry based on HLA donor–recipient confirmatory typings. A total of 28 HLA‐A, 61 HLA‐B, 30 HLA‐Cw, 40 HLA‐DRB1 and 18 HLA‐DQB1 alleles were identified, and HLA‐A*1101, A*2402, A*0201, B*4001, Cw*0702, Cw*0102, Cw*0304, DRB1*0901, DRB1*1501, DQB1*0301, DQB1*0303 and DQB1*0601 were found with frequencies higher than 10% in this study population. Multiple‐locus haplotype analysis by the maximum‐likelihood method revealed 45 A–B, 38 Cw–B, 47 B–DRB1, 29 DRB1–DQB1, 24 A–B–DRB1, 38 A–Cw–B, 23 A–Cw–B–DRB1, 33 Cw–B–DRB1–DQB1 and 22 A–Cw–B–DRB1–DQB1 haplotypes with frequencies >0.5%. The most common two‐, three‐, four‐ and five‐locus haplotypes in this population were: A*0207–B*4601 (7.34%), Cw*0102–B*4601 (8.71%), B*1302–DRB1*0701 (6.19%), DRB1*0901–DQB1*0303 (14.27%), A*3001–B*1302–DRB1*0701 (5.36%), A*0207–Cw*0102–B*4601 (7.06%), A*3001–Cw*0602–B*1302–DRB1*0701 (5.36%), Cw*0602–B*1302–DRB1*0701–DQB1*0202 (6.12%) and A*3001–Cw*0602–B*1302–DRB1*0701–DQB1*0202 (5.29%). Presentation of the high‐resolution alleles and haplotypes data at HLA‐A, ‐B, ‐Cw, ‐DRB1 and ‐DQB1 loci will be useful for HLA matching in transplantation as well as for other medical and anthropological applications in the Chinese population.     

DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans

The association of narcolepsy with HLA-DQB1*0602 is established in Japanese, African-Americans, European, and North American Caucasians. We examined DRB1, DRB3, DRB4, DRB5, DQA1, and DQB1 in 163 patients with centrally mediated daytime sleepiness (100 with narcolepsy) and 211 Korean controls. In this population, the DQB1*0602 association was always evident in the context of the DRB1*1501-DQA1*0102-DQB1*0602 haplotype. The DQB1*0602 association was highest in cases with hypocretin deficiency (100% vs 13% in controls), most of which had narcolepsy-cataplexy (81%). A weaker DQB1*0602 (45%) association was present in cases without cataplexy. No human leukocyte antigen (HLA) association was present in idiopathic hypersomnia or in cases with normal cerebrospinal fluid (CSF) hypocretin-1. As in other populations, DQB1*0602 homozygosity increased risk in cases with cataplexy and/or hypocretin deficiency (odds ratio = 2.0 vs heterozygotes). Non-DQB1*0602 allelic effects were also observed but could not be interpreted in the context of DQB1*0602 overabundance and linkage disequilibrium. We therefore next analyzed compound heterozygote effects in 77 subjects with either hypocretin deficiency or cataplexy and one copy of DRB1*1501-DQA1*0102-DQB1*0602, a sample constructed to maximize etiologic homogeneity. In this analysis, we found additional predisposing effects of DQB1*0301 and protective effects for DQA1*0103-DQB1*0601. Unexpectedly, the predisposing effects of DQB1*0301 were present in the context of various DQA1-bearing haplotypes. A predisposing effect of DQA1*0303 was also suggested. These results indicate a remarkable consistency in the complex HLA association present in narcolepsy across multiple ethnic groups.     

High-resolution HLA typing for the DQB1 gene by sequence-based typing

Abstract: The ideal high-resolution typing strategy for polymorphic genes is sequence-based typing. SBT of genomic DNA has been developed for the HLA class H genes DRB1, DRB3/4/5 and DPB1. For the DQB1 gene the sequence-based typing method was shown to cause a number of problems. To resolve those problems, different primers to amplify and sequence exon 2 of DQB1 were designed and tested. With several primer combinations, preferential amplification was observed in individuals heterozygous for DQB1*02/*03 and DQB1*02/*04. The preference was for DQB1*02 in many instances but could also be demonstrated for DQB1*03 or *04 and resulted occasionally in allelic drop-out. The best primer combination was selected and successfully used to type individuals heterozygous for DQB1*02, *03 and*04. To distinguish DQB1*0201 and *0202, primers for amplification and sequencing of exon 3 were developed and correct subtyping was obtained. The ambiguous typing DQB1*0301/*0302 and DQB1*0303/*0304 was resolved by allele-specifk amplification and sequencing. A total of 258 individuals were fully typed for their DQB1 subtypes. All samples had been previously typed by PCR-SSP and serology. Concordant typing results were obtained for all individuals tested. The DQB1 alleles detected included *0501, *0502, *0503, *0601, *0602, *0603, *0604, *0609, *0201, *0202, *0301, *0302, *0303, *0304, *0401 and *0402. Sequence-based typing of the DQB1 gene proved a reliable typing strategy for assignment of the different DQB1 alleles after intensive selection of primers and test conditions.     

Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang,China

Human papillomavirus (HPV) infection is a major risk factor for cervical cancer. However, only some high risk human papillomavirus (HR-HPV)-infected women progress to cervical cancer, host immunogenetic factors human leukocyte antigen (HLA) may account for viral antigens presenting individually or together in the progression to cervical cancer. This study examined the association between the development of invasive cervical cancer (ICC) and the determinant factors including HLA-DRB1*1501 and DQB1*0602, HR-HPV infection among Chinese Uighur and Han populations. Blood samples, cervical swabs and biopsies were obtained from 287 patients with ICC (192 Uighurs and 95 Hans) and 312 healthy controls (218 Uighurs and 94 Hans). HPV DNA was detected by PCR and HLA-DRB1*1501 and DQB1*0602 alleles were performed using PCR-SSP method. HPV16 infection rates was significantly higher among Uighur and Han with ICC as compared to healthy controls (OR = 58.317; 95% CI: 39.663-85.744; OR = 33.778; 95% CI: 12.581-90.691; P < 0.05 for all). HLA-DRB1*1501 (OR = 0.305; 95% CI: 0.115-0.813; P < 0.05) and HLA-DRB1*1501-DQB1*0602 haplotype frequencies (OR = 0.274; 95% CI: 0.086-0.874; P < 0.05) were significantly reduced in Han ICC. The HLA-DQB1*0602 frequency significantly decreased among Uighur women with ICC (OR = 0.482; 95% CI: 0.325-0.716; P < 0.05). Similar tendencies were observed for DQB1*0602 with HPV16-positive ICC (OR = 0.550; 95% CI: 0.362-0.837; P < 0.05). This study suggests that HLA-DRB1*1501 and DQB1*0602 alleles may influence the immune response to HPV16 infection and decrease the risk of ICC among Uighurs and Hans in Xinjiang, China.     

家族性重症肌无力与HLA-DQB1等位基因多态性的相关性

目的探讨中国北方地区家族性重症肌无力（myasthenia gravis，MG）与HLA-DQB1等位基因多态性的相互关系。方法应用聚合酶链反应．序列特异性引物方法对中国北方地区15例家族性MG、49例散发性MG和51名健康对照组的HLA-DQB1基因多态性进行分析。结果在家族性MG中DQB1＊0501等位基因频率明显高于散发MG（P〈0．05，OR：3．08）和对照（P=0．001，OR=4．439），尤其是眼型患者更加显著有统计学意义（P〈0．01，OR=7．67）。结论DQB1＊0501等位基因是家族性MG尤其是眼型患者的易感基因；遗传因素与重症肌无力发生密切相关。家族性MG有其独特的临床特点。     

Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602--positive subjects

The purpose of this study was to investigate the association of human leukocyte antigen (HLA) class II alleles with narcolepsy-cataplexy susceptibility in Koreans. The distribution of HLA-DRB1 and -DQB1 alleles and presence or absence of DRB3/4/5 alleles were examined in 60 narcoleptic patients with clear-cut cataplexy, and the results were compared with two groups of healthy controls: 200 randomly selected controls and 144 DRB1*1501-DQB1*0602 positive controls. All of the narcoleptic patients were DRB1*1501 and DQB1*0602 positive, and their frequencies were significantly higher in patients than in random controls (100% vs 17.0%, p(c) = 2.3 x 10(-30), OR = 583.96; 100% vs 16.5%, p(c) = 3.9 x 10(-31), OR = 605.00). The HLA association in Koreans was as tight as that reported in Japanese. Several DRB1 (*0101, *0405, *0901) and DQB1 alleles (*0303, *0401, *0501, *0601, *0604) were found to have weak protective effects against narcolepsy. DRB4 showed strong protective effect, and this was also significant when compared with DRB1*1501-DQB1*0602 positive controls (18.3% vs 44.4%, p(c) = 0.001, OR = 0.28). DRB3 (OR = 1.86) and DQB1*0301 (OR = 2.45) were found to have weak predisposing effect, when compared with DRB1*1501-DQB1*0602 positive controls. The protective effect of DRB4 has to be further studied in other populations.